AIMS: To identify factors associated with the Staphylococcus aureus pine-oil disinfectant-reduced-susceptibility (PD(RS)) mechanism and to describe one possible PD(RS) model. METHODS AND RESULTS: Comparative genomic sequencing (CGS) and microarray analysis were utilized to detect mutations and transcriptome alterations that occur in a S. aureus PD(RS) mutant. Mutant analysis, antimicrobial gradient plates, growth studies and 3-hydroxy-3-methylglutaryl coenzyme A synthase assays were then performed to confirm the biological consequences of the 'omics' alterations detected in a PD(RS) mutant. CGS uncovered three mutations in a PD(RS) mutant in a(n): alcohol dehydrogenase (adh), catabolite control protein A (ccpA) and an NADPH-flavin oxidoreductase (frp). These mutations lead to increased growth rates; increased transcription of an NAD-dependent D-lactate dehydrogenase gene (ddh); and increased flux through the mevalonate pathway. PD(RS) mutants demonstrated reduced susceptibility to bacitracin and farnesol, and one PD(RS) mutant displayed upregulation of bacA, a bacitracin-resistance gene. Collectively, this evidence demonstrates altered undecaprenol metabolism in PD(RS) mutants. CONCLUSIONS: The PD(RS) mechanism proposed results from increased catabolic capabilities and increased flux through the mevalonate pathway as well as altered bactoprenol physiology. SIGNIFICANCE AND IMPACT OF THE STUDY: A novel mechanism that bacteria utilize to overcome the killing effects of PD formulations is proposed that is unique from the PD(RS) mechanism of the enterobacteraciae.
AIMS: To identify factors associated with the Staphylococcus aureuspine-oil disinfectant-reduced-susceptibility (PD(RS)) mechanism and to describe one possible PD(RS) model. METHODS AND RESULTS: Comparative genomic sequencing (CGS) and microarray analysis were utilized to detect mutations and transcriptome alterations that occur in a S. aureusPD(RS) mutant. Mutant analysis, antimicrobial gradient plates, growth studies and 3-hydroxy-3-methylglutaryl coenzyme A synthase assays were then performed to confirm the biological consequences of the 'omics' alterations detected in a PD(RS) mutant. CGS uncovered three mutations in a PD(RS) mutant in a(n): alcohol dehydrogenase (adh), catabolite control protein A (ccpA) and an NADPH-flavin oxidoreductase (frp). These mutations lead to increased growth rates; increased transcription of an NAD-dependent D-lactate dehydrogenase gene (ddh); and increased flux through the mevalonate pathway. PD(RS) mutants demonstrated reduced susceptibility to bacitracin and farnesol, and one PD(RS) mutant displayed upregulation of bacA, a bacitracin-resistance gene. Collectively, this evidence demonstrates altered undecaprenol metabolism in PD(RS) mutants. CONCLUSIONS: The PD(RS) mechanism proposed results from increased catabolic capabilities and increased flux through the mevalonate pathway as well as altered bactoprenol physiology. SIGNIFICANCE AND IMPACT OF THE STUDY: A novel mechanism that bacteria utilize to overcome the killing effects of PD formulations is proposed that is unique from the PD(RS) mechanism of the enterobacteraciae.
Authors: Thomas J Albert; Daiva Dailidiene; Giedrius Dailide; Jason E Norton; Awdhesh Kalia; Todd A Richmond; Michael Molla; Jaz Singh; Roland D Green; Douglas E Berg Journal: Nat Methods Date: 2005-11-18 Impact factor: 28.547
Authors: James T Riordan; Arunachalam Muthaiyan; Wayne Van Voorhies; Christopher T Price; James E Graham; Brian J Wilkinson; John E Gustafson Journal: J Bacteriol Date: 2006-10-20 Impact factor: 3.490
Authors: Steven R Gill; Derrick E Fouts; Gordon L Archer; Emmanuel F Mongodin; Robert T Deboy; Jacques Ravel; Ian T Paulsen; James F Kolonay; Lauren Brinkac; Mauren Beanan; Robert J Dodson; Sean C Daugherty; Ramana Madupu; Samuel V Angiuoli; A Scott Durkin; Daniel H Haft; Jessica Vamathevan; Hoda Khouri; Terry Utterback; Chris Lee; George Dimitrov; Lingxia Jiang; Haiying Qin; Jan Weidman; Kevin Tran; Kathy Kang; Ioana R Hance; Karen E Nelson; Claire M Fraser Journal: J Bacteriol Date: 2005-04 Impact factor: 3.490
Authors: George Y Liu; Anthony Essex; John T Buchanan; Vivekanand Datta; Hal M Hoffman; John F Bastian; Joshua Fierer; Victor Nizet Journal: J Exp Med Date: 2005-07-11 Impact factor: 14.307
Authors: Jesus A Cuaron; Santosh Dulal; Peter H Cooke; Nathanial J Torres; John E Gustafson Journal: Phytother Res Date: 2014-02-12 Impact factor: 5.878
Authors: Bernadette C Young; Chieh-Hsi Wu; N Claire Gordon; Kevin Cole; James R Price; Elian Liu; Anna E Sheppard; Sanuki Perera; Jane Charlesworth; Tanya Golubchik; Zamin Iqbal; Rory Bowden; Ruth C Massey; John Paul; Derrick W Crook; Timothy E Peto; A Sarah Walker; Martin J Llewelyn; David H Wyllie; Daniel J Wilson Journal: Elife Date: 2017-12-19 Impact factor: 8.140